Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-22-008893
Filing Date
2022-05-20
Accepted
2022-05-20 09:22:37
Documents
16
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp173399_6k.htm 6-K 12552
2 EXHIBIT 99.1 dp173399_ex9901.htm EX-99.1 64010
3 EXHIBIT 99.2 dp173399_ex9902.htm EX-99.2 7958
4 EXHIBIT 99.3 dp173399_ex9903.htm EX-99.3 1711
5 EXHIBIT 99.4 dp173399_ex9904.htm EX-99.4 1763
6 EXHIBIT 99.5 dp173399_ex9905.htm EX-99.5 98168
7 GRAPHIC image_001.jpg GRAPHIC 9981
8 GRAPHIC image_002.jpg GRAPHIC 2823
9 GRAPHIC image_005.jpg GRAPHIC 70584
10 GRAPHIC image_006.jpg GRAPHIC 121602
11 GRAPHIC ex9902a.jpg GRAPHIC 470435
12 GRAPHIC ex9902b.jpg GRAPHIC 554837
13 GRAPHIC ex9903a.jpg GRAPHIC 246968
14 GRAPHIC ex9903b.jpg GRAPHIC 636982
15 GRAPHIC ex9904a.jpg GRAPHIC 182847
16 GRAPHIC ex9904b.jpg GRAPHIC 612799
  Complete submission text file 0000950103-22-008893.txt   4196294
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 22945705
SIC: 2834 Pharmaceutical Preparations